miR-126 and miR-126*: New players in cancer

TheScientificWorldJournal

Volumn 10, Issue , 2010, Pages 2090-2100

  Meister, Jeannette ^a   Schmidt, Mirko H H ^a  

^a GOETHE UNIVERSITY MEDICAL SCHOOL   (Germany)

Author keywords

Cancer; EGFL7; Epidermal growth factor like domain 7; microRNA; miR 126; miR 126*

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR LIKE DOMAIN 7; MICRORNA; MICRORNA 126; UNCLASSIFIED DRUG; EGFL7 PROTEIN, HUMAN; ENDOTHELIAL CELL GROWTH FACTOR; MIRN126 MICRORNA, HUMAN;

ANGIOGENESIS; CANCER GROWTH; CARDIOVASCULAR FUNCTION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; GENE EXPRESSION; INTRON; NONHUMAN; SHORT SURVEY; TUMOR CELL; ZEBRA FISH; ANIMAL; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; NEOPLASM; NUCLEOTIDE SEQUENCE; PATHOLOGY; REVIEW;

DANIO RERIO; MUS;

ANIMALS; BASE SEQUENCE; ENDOTHELIAL CELLS; ENDOTHELIAL GROWTH FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRONS; MICRORNAS; MOLECULAR SEQUENCE DATA; NEOPLASMS;

EID: 78349251242     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2010.198     Document Type: Short Survey

References (65)

1. Lee, R.C., Feinbaum, R.L., and Ambros, V. (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75, 843-854.
2. Calin, G.A. and Croce, C.M. (2006) MicroRNA signatures in human cancers. Nat. Rev. Cancer 6, 857-866.
3. Li, X., Zhang, Y., Zhang, Y., Ding, J., Wu, K., and Fan, D. (2010) Survival prediction of gastric cancer by a seven-microRNA signature. Gut 59, 579-585.
4. Hu, Y., Correa, A.M., Hoque, A., Guan, B., Ye, F., Huang, J., Swisher, S.G., Wu, T.T., Ajani, J.A., and Xu, X.C. (2010) Prognostic significance of differentially expressed miRNAs in esophageal cancer. Int. J. Cancer. [Epub ahead of print]
5. Zhang, H., Luo, X.Q., Zhang, P., Huang, L.B., Zheng, Y.S., Wu, J., Zhou, H., Qu, L.H., Xu, L., and Chen, Y.Q. (2009) MicroRNA patterns associated with clinical prognostic parameters and CNS relapse prediction in pediatric acute leukemia. PLoS One 4, e7826.
6. Lu, J., Getz, G., Miska, E.A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B.L., Mak, R.H., Ferrando, A.A., Downing, J.R., Jacks, T., Horvitz, H.R., and Golub, T.R. (2005) MicroRNA expression profiles classify human cancers. Nature 435, 834-838.
7. Tavazoie, S.F., Alarcon, C., Oskarsson, T., Padua, D., Wang, Q., Bos, P.D., Gerald, W.L., and Massague, J. (2008) Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451, 147-152.
8. Mitchell, P.S., Parkin, R.K., Kroh, E.M., Fritz, B.R., Wyman, S.K., Pogosova-Agadjanyan, E.L., Peterson, A., Noteboom, J., O'Briant, K.C., Allen, A., Lin, D.W., Urban, N., Drescher, C.W., Knudsen, B.S., Stirewalt, D.L., Gentleman, R., Vessella, R.L., Nelson, P.S., Martin, D.B., and Tewari, M. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. U. S. A. 105, 10513-10518.
9. Suarez, Y., Fernandez-Hernando, C., Yu, J., Gerber, S.A., Harrison, K.D., Pober, J.S., Iruela-Arispe, M.L., Merkenschlager, M., and Sessa, W.C. (2008) Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis. Proc. Natl. Acad. Sci. U. S. A. 105, 14082-14087.
10. Wang, S., Aurora, A.B., Johnson, B.A., Qi, X., McAnally, J., Hill, J.A., Richardson, J.A., Bassel-Duby, R., and Olson, E.N. (2008) The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev. Cell 15, 261-271.
11. Shen, W.F., Hu, Y.L., Uttarwar, L., Passegue, E., and Largman, C. (2008) MicroRNA-126 regulates HOXA9 by binding to the homeobox. Mol. Cell. Biol. 28, 4609-4619. (Pubitemid 351977758)
12. Fish, J.E., Santoro, M.M., Morton, S.U., Yu, S., Yeh, R.F., Wythe, J.D., Ivey, K.N., Bruneau, B.G., Stainier, D.Y., and Srivastava, D. (2008) miR-126 regulates angiogenic signaling and vascular integrity. Dev. Cell 15, 272-284.
13. Negrini, M. and Calin, G.A. (2008) Breast cancer metastasis: a microRNA story. Breast Cancer Res. 10, 203.
14. Wang, X., Tang, S., Le, S.Y., Lu, R., Rader, J.S., Meyers, C., and Zheng, Z.M. (2008) Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One 3, e2557.
15. Diaz, R., Silva, J., Garcia, J.M., Lorenzo, Y., Garcia, V., Pena, C., Rodriguez, R., Munoz, C., Garcia, F., Bonilla, F., and Dominguez, G. (2008) Deregulated expression of miR-106a predicts survival in human colon cancer patients. Genes Chromosomes Cancer 47, 794-802.
16. Crawford, M., Brawner, E., Batte, K., Yu, L., Hunter, M.G., Otterson, G.A., Nuovo, G., Marsh, C.B., and Nana- Sinkam, S.P. (2008) MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines. Biochem. Biophys. Res. Commun. 373, 607-612.
17. Ladeiro, Y., Couchy, G., Balabaud, C., Bioulac-Sage, P., Pelletier, L., Rebouissou, S., and Zucman-Rossi, J. (2008) MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology 47, 1955-1963.
18. Musiyenko, A., Bitko, V., and Barik, S. (2008) Ectopic expression of miR-126*, an intronic product of the vascular endothelial EGF-like 7 gene, regulates prostein translation and invasiveness of prostate cancer LNCaP cells. J. Mol. Med. 86, 313-322.
19. Li, Z., Lu, J., Sun, M., Mi, S., Zhang, H., Luo, R.T., Chen, P., Wang, Y., Yan, M., Qian, Z., Neilly, M.B., Jin, J., Zhang, Y., Bohlander, S.K., Zhang, D.E., Larson, R.A., Le Beau, M.M., Thirman, M.J., Golub, T.R., Rowley, J.D., and Chen, J. (2008) Distinct microRNA expression profiles in acute myeloid leukemia with common translocations. Proc. Natl. Acad. Sci. U. S. A. 105, 15535-15540.
20. Saito, Y., Friedman, J.M., Chihara, Y., Egger, G., Chuang, J.C., and Liang, G. (2009) Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells. Biochem. Biophys. Res. Commun. 379, 726-731.
21. Feng, R., Chen, X., Yu, Y., Su, L., Yu, B., Li, J., Cai, Q., Yan, M., Liu, B., and Zhu, Z. (2010) miR-126 functions as a tumour suppressor in human gastric cancer. Cancer Lett. 298, 50-63.
22. Bartel, D.P. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297.
23. Wu, L. and Belasco, J.G. (2008) Let me count the ways: mechanisms of gene regulation by miRNAs and siRNAs. Mol. Cell 29, 1-7.
24. Bartel, D.P. (2009) MicroRNAs: target recognition and regulatory functions. Cell 136, 215-233.
25. Filipowicz, W., Bhattacharyya, S.N., and Sonenberg, N. (2008) Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat. Rev. Genet. 9, 102-114.
26. Rodriguez, A., Griffiths-Jones, S., Ashurst, J.L., and Bradley, A. (2004) Identification of mammalian microRNA host genes and transcription units. Genome Res. 14, 1902-1910.
27. Monteys, A.M., Spengler, R.M., Wan, J., Tecedor, L., Lennox, K.A., Xing, Y., and Davidson, B.L. (2010) Structure and activity of putative intronic miRNA promoters. RNA 16, 495-505.
28. Lee, Y., Kim, M., Han, J., Yeom, K.H., Lee, S., Baek, S.H., and Kim, V.N. (2004) MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 23, 4051-4060. (Pubitemid 39472426)
29. Lee, Y., Jeon, K., Lee, J.T., Kim, S., and Kim, V.N. (2002) MicroRNA maturation: stepwise processing and subcellular localization. EMBO J. 21, 4663-4670.
30. Han, J., Lee, Y., Yeom, K.H., Kim, Y.K., Jin, H., and Kim, V.N. (2004) The Drosha-DGCR8 complex in primary microRNA processing. Genes Dev. 18, 3016-3027.
31. Yi, R., Qin, Y., Macara, I.G., and Cullen, B.R. (2003) Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev. 17, 3011-3016. (Pubitemid 38040764)
32. Bernstein, E., Caudy, A.A., Hammond, S.M., and Hannon, G.J. (2001) Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409, 363-366. (Pubitemid 32151243)
33. Hammond, S.M., Bernstein, E., Beach, D., and Hannon, G.J. (2000) An RNA-directed nuclease mediates posttranscriptional gene silencing in Drosophila cells. Nature 404, 293-296.
34. Martinez, J., Patkaniowska, A., Urlaub, H., Luhrmann, R., and Tuschl, T. (2002) Single-stranded antisense siRNAs guide target RNA cleavage in RNAi. Cell 110, 563-574.
35. Soncin, F., Mattot, V., Lionneton, F., Spruyt, N., Lepretre, F., Begue, A., and Stehelin, D. (2003) VE-statin, an endothelial repressor of smooth muscle cell migration. EMBO J. 22, 5700-5711.
36. Fitch, M.J., Campagnolo, L., Kuhnert, F., and Stuhlmann, H. (2004) Egfl7, a novel epidermal growth factor-domain gene expressed in endothelial cells. Dev. Dyn. 230, 316-324. (Pubitemid 38669592)
37. Parker, L.H., Schmidt, M., Jin, S.W., Gray, A.M., Beis, D., Pham, T., Frantz, G., Palmieri, S., Hillan, K., Stainier, D.Y., De Sauvage, F.J., and Ye, W. (2004) The endothelial-cell-derived secreted factor Egfl7 regulates vascular tube formation. Nature 428, 754-758.
38. Nikolic, I., Plate, K.H., and Schmidt, M.H. (2010) EGFL7 meets miRNA-126: an angiogenesis alliance. J. Angiogenes Res. 2, 9.
39. Campagnolo, L., Moscatelli, I., Pellegrini, M., Siracusa, G., and Stuhlmann, H. (2008) Expression of EGFL7 in primordial germ cells and in adult ovaries and testes. Gene Expr. Patterns 8, 389-396.
40. Campagnolo, L., Leahy, A., Chitnis, S., Koschnick, S., Fitch, M.J., Fallon, J.T., Loskutoff, D., Taubman, M.B., and Stuhlmann, H. (2005) EGFL7 is a chemoattractant for endothelial cells and is up-regulated in angiogenesis and arterial injury. Am. J. Pathol. 167, 275-284.
41. Schmidt, M.H., Bicker, F., Nikolic, I., Meister, J., Babuke, T., Picuric, S., Muller-Esterl, W., Plate, K.H., and Dikic, I. (2009) Epidermal growth factor-like domain 7 (EGFL7) modulates Notch signalling and affects neural stem cell renewal. Nat. Cell Biol. 11, 873-880.
42. Bicker, F. and Schmidt, M.H. (2010) EGFL7: a new player in homeostasis of the nervous system. Cell Cycle 9. [Epub ahead of print]
43. Lagos-Quintana, M., Rauhut, R., Yalcin, A., Meyer, J., Lendeckel, W., and Tuschl, T. (2002) Identification of tissue-specific microRNAs from mouse. Curr. Biol. 12, 735-739.
44. Landgraf, P., Rusu, M., Sheridan, R., Sewer, A., Iovino, N., Aravin, A., Pfeffer, S., Rice, A., Kamphorst, A.O., Landthaler, M., Lin, C., Socci, N.D., Hermida, L., Fulci, V., Chiaretti, S., Foa, R., Schliwka, J., Fuchs, U., Novosel, A., Muller, R.U., Schermer, B., Bissels, U., Inman, J., Phan, Q., Chien, M., Weir, D.B., Choksi, R., De Vita, G., Frezzetti, D., Trompeter, H.I., Hornung, V., Teng, G., Hartmann, G., Palkovits, M., Di Lauro, R., Wernet, P., Macino, G., Rogler, C.E., Nagle, J.W., Ju, J., Papavasiliou, F.N., Benzing, T., Lichter, P., Tam, W., Brownstein, M.J., Bosio, A., Borkhardt, A., Russo, J.J., Sander, C., Zavolan, M., and Tuschl, T. (2007) A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129, 1401-1414.
45. Harris, T.A., Yamakuchi, M., Ferlito, M., Mendell, J.T., and Lowenstein, C.J. (2008) MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc. Natl. Acad. Sci. U. S. A. 105, 1516-1521. (Pubitemid 351346546)
46. Kuehbacher, A., Urbich, C., Zeiher, A.M., and Dimmeler, S. (2007) Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis. Circ. Res. 101, 59-68.
47. Liu, B., Peng, X.C., Zheng, X.L., Wang, J., and Qin, Y.W. (2009) MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo. Lung Cancer 66, 169-175.
48. Izzotti, A., Calin, G.A., Arrigo, P., Steele, V.E., Croce, C.M., and De Flora, S. (2009) Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke. FASEB J. 23, 806-812.
49. Li, X., Shen, Y., Ichikawa, H., Antes, T., and Goldberg, G.S. (2009) Regulation of miRNA expression by Src and contact normalization: effects on nonanchored cell growth and migration. Oncogene 28, 4272-4283.
50. Yanaihara, N., Caplen, N., Bowman, E., Seike, M., Kumamoto, K., Yi, M., Stephens, R.M., Okamoto, A., Yokota, J., Tanaka, T., Calin, G.A., Liu, C.G., Croce, C.M., and Harris, C.C. (2006) Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9, 189-198.
51. Cho, W.C., Chow, A.S., and Au, J.S. (2009) Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation. Eur. J. Cancer 45, 2197-2206.
52. Guo, C., Sah, J.F., Beard, L., Willson, J.K., Markowitz, S.D., and Guda, K. (2008) The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers. Genes Chromosomes Cancer 47, 939-946.
53. Birge, R.B., Kalodimos, C., Inagaki, F., and Tanaka, S. (2009) Crk and CrkL adaptor proteins: networks for physiological and pathological signaling. Cell Commun. Signal. 7, 13.
54. Nicoli, S., Standley, C., Walker, P., Hurlstone, A., Fogarty, K.E., and Lawson, N.D. (2010) MicroRNA-mediated integration of haemodynamics and Vegf signalling during angiogenesis. Nature 464, 1196-1200.
55. Fish, J.E. and Srivastava, D. (2009) MicroRNAs: opening a new vein in angiogenesis research. Sci. Signal. 2, pe1.
56. Kuhnert, F., Mancuso, M.R., Hampton, J., Stankunas, K., Asano, T., Chen, C.Z., and Kuo, C.J. (2008) Attribution of vascular phenotypes of the murine Egfl7 locus to the microRNA miR-126. Development 135, 3989-3993.
57. Hussain, S.P. and Harris, C.C. (2007) Inflammation and cancer: an ancient link with novel potentials. Int. J. Cancer 121, 2373-2380. (Pubitemid 350022405)
58. Taganov, K.D., Boldin, M.P., Chang, K.J., and Baltimore, D. (2006) NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. U. S. A. 103, 12481-12486.
59. Wu, F., Zikusoka, M., Trindade, A., Dassopoulos, T., Harris, M.L., Bayless, T.M., Brant, S.R., Chakravarti, S., and Kwon, J.H. (2008) MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. Gastroenterology 135, 1624-1635.e24.
60. Huang, H., Bhat, A., Woodnutt, G., and Lappe, R. (2010) Targeting the ANGPT-TIE2 pathway in malignancy. Nat. Rev. Cancer 10, 575-585.
61. Chen, J.F., Mandel, E.M., Thomson, J.M., Wu, Q., Callis, T.E., Hammond, S.M., Conlon, F.L., and Wang, D.Z. (2006) The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet. 38, 228-233.
62. Bergers, G. and Hanahan, D. (2008) Modes of resistance to anti-angiogenic therapy. Nat. Rev. Cancer 8, 592-603.
63. Kumar, M.S., Lu, J., Mercer, K.L., Golub, T.R., and Jacks, T. (2007) Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat. Genet. 39, 673-677.
64. Lopez-Fraga, M., Martinez, T., and Jimenez, A. (2009) RNA interference technologies and therapeutics: from basic research to products. BioDrugs 23, 305-332.
65. Kota, J., Chivukula, R.R., O'Donnell, K.A., Wentzel, E.A., Montgomery, C.L., Hwang, H.W., Chang, T.C., Vivekanandan, P., Torbenson, M., Clark, K.R., Mendell, J.R., and Mendell, J.T. (2009) Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 137, 1005-1017.